Rural Pharmacies’ Threat: Castellón’s Critique of Drug Project
Castellón Health Professionals Divided Over Proposed Drug Law
Healthcare professionals in the province of Castellón have expressed differing opinions regarding the preliminary draft of the law on medicines and health products. While the Nursing Association views the regulatory reform as a step forward,as it includes them among healthcare providers with the ability to prescribe drugs,doctors are concerned about the potential negative impact on patient safety. There is even greater concern among pharmacists,who warn that it could lead to a massive closure of rural pharmacies.
Physicians’ concerns
Carlos Vilar, president of the Castellón Medical Association, believes that “the prescription of medications is fundamentally a obligation of the medical profession, and therefore, we reject any measure that grants new professionals without sufficient training the power to prescribe medications.”
Vilar also notes the importance of patient safety and health. “When prescribing a medication, it is necessary to consider, among other things, the medical record and the possible consequences on previously diagnosed pathologies. Doctors have the authority and training to do so,” he said, insisting that “patient safety is an essential priority.”
The preliminary draft, approved by the Council of Ministers this April, enables nursing and physiotherapy professionals to prescribe medications, which, according to the government, increases the number of professionals who can prescribe.
Government’s Defense
Conversely,the government defends that the tiered pricing system will allow greater competition among producers,greater and more agile incorporation of generic and biosimilar drugs,in addition to allowing drugs that wish to differentiate themselves in price,entering or not entering the group of drugs with selected prices. The offer of selected prices would be updated every six months by the companies concerned, allowing price revisions based on different factors that may affect the production of medicines.
Addressing Shortages
The law also incorporates measures to reduce supply problems. Currently,when there is a supply problem with a particular drug presentation (for example,a specific shortage of tablets,with the same active ingredient available in other presentations such as capsules),patients must return to the health center for the doctor to prescribe the same medication with the pharmaceutical presentation that is available.This situation creates a negative experience for both the patient and the prescribing professional,as well as reducing the efficiency of the system. The law will allow the pharmacist to dispense another equivalent within the list of substitutable drugs. Thus, if the same active ingredient exists but in sachets instead of pills, such as, it will not be necessary to return to the doctor for another prescription. the Spanish Agency for Medicines and Health Products (AEMPS) has recorded supply problems with up to 760 medicines, a figure that varies in real time on its website.
one of the objectives of the law is to reduce healthcare spending, which is trending upward. in Castellón alone, spending on prescriptions increased from 192.4 million in 2022 to 202.590 million in 2023, an increase of 5.3%, according to the latest data available in the yearbook of the Economic and Social Committee (CES) of the Comunitat.
Castellón Drug Law: Your Questions Answered
Here’s a breakdown of the proposed drug law in castellón, addressing key concerns and providing clarity on the changes.We’ll cut through the jargon and explain the potential impact on healthcare professionals, patients, and the healthcare system.
What is the proposed drug law in Castellón about?
the proposed law concerns medicines and health products and has created division among healthcare professionals. The main provisions address drug prescription authority, drug pricing, and measures to address drug shortages in castellón.
Who supports and opposes the proposed law, and why?
The proposed changes have sparked significant debate. Here’s a summary of the key stakeholders and their perspectives:
Nursing Association: Supports the law as it allows them to prescribe certain medications.
Doctors (Castellón Medical Association): Oppose the law, primarily due to concerns about patient safety and the potential for less-qualified professionals to prescribe medications. They argue that physicians have the necessary training and understanding of patient medical records to ensure safe and effective prescriptions.
Pharmacists: Express concerns that the proposed law could lead to a decline in rural pharmacies and their presence.
What are the physicians’ main concerns about the law?
Doctors are primarily concerned about patient safety. They emphasize their expertise in evaluating medical records and considering pre-existing conditions when prescribing medications. They believe that allowing other healthcare professionals to prescribe medications without the same level of training could increase the risk of adverse health outcomes.Carlos Vilar, the president of the Castellón Medical Association, has been outspoken about these concerns.
How does the proposed law impact who can prescribe medications?
the preliminary draft of the law, approved by the Council of Ministers, extends prescription authority to nursing and physiotherapy professionals.this measure has generated controversy, as doctors believe the current training is insufficient.
How will the new law affect drug pricing?
The law introduces a tiered pricing system for medications, aiming to increase competition among pharmaceutical producers. The government defends the use of a “selected prices” list based on different factors that influence production costs with revisions every six months. This system aims to facilitate the introduction of generic and biosimilar drugs.
What measures are included to address drug shortages?
The law contains provisions to mitigate issues with drug shortages:
Current Situation: When a specific drug presentation (e.g., a tablet) is unavailable but the active ingredient is available in another form (e.g., capsules), patients currently need to return to their doctor for a new prescription.
Proposed Solution: The new law would allow pharmacists to dispense an equivalent choice from a list of substitutable drugs (e.g., dispensing sachets rather of pills) avoiding the need for the patient to revisit the doctor.
Severity of the Problem: The Spanish Agency for Medicines and Health Products (AEMPS) has documented supply problems with up to 760 different medicines,so the changes would have a notable impact.
How might the law influence healthcare spending?
One of the law’s objectives is to reduce rising healthcare costs. Prescription spending in Castellón increased by 5.3% from 2022 to 2023, rising from 192.4 million to 202.590 million, according to data from the Economic and Social Committee (CES) of the Comunitat. The proposed law is expected to help decrease these expenditures.
What are the potential benefits of the law?
Increased drug competition: The tiered pricing system could encourage greater competition, perhaps leading to lower drug prices.
Easier access to medications: Patients may find it easier to obtain medications, particularly in cases of drug shortages, without requiring multiple trips to the doctor.
Cost savings: There is a goal of reducing healthcare spending, which could create more efficiency in the healthcare system.
What are the potential drawbacks of the law?
patient safety concerns: Doctors worry about the potential impact of non-physicians prescribing medications, which could affect patient outcomes.
* Impact on rural pharmacies: The law could lead to the closure of rural pharmacies.
Summary of Key Points
To quickly recap the central considerations, here’s a table condensing the critical aspects of the drug law debate:
| Aspect | Details |
|---|---|
| main Objective | To reform the prescription of drugs and to ease supply problems. |
| Key Stakeholders | Doctors (opposed), Nurses (support), Pharmacists (concerned) |
| Primary Concern (Doctors) | Patient safety due to less qualified prescribers. |
| Prescription Authority Changes | Nurses,and physiotherapists allowed to prescribe medications. |
| Pricing System | tiered pricing to promote competition and biosimilar and generic drug inclusion. |
| supply Shortages | Pharmacists can dispense equivalent drugs when shortages happen. |
| Impact on Spending | Designed to decrease healthcare spending. |